Free Trial
→ REVEALED: Elon’s Secret Master Plan “AGENDA X” (From Brownstone Research) (Ad) Buy OCS Stock  Free OCS Stock Alerts

Oculis (OCS) Financials

Oculis logo
$18.25 -0.32 (-1.72%)
As of 04:00 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.
Compare
Annual Income Statements for Oculis

Annual Income Statements for Oculis

This table shows Oculis' income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2020 2021 2022 2023 2024
Period end date 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024
Net Income / (Loss) Attributable to Common Shareholders		 -17 -20 -42 -106 -95
Consolidated Net Income / (Loss)		 -17 -20 -42 -106 -95
Net Income / (Loss) Continuing Operations		 -17 -20 -42 -106 -95
Total Pre-Tax Income 		-17 -20 -42 -106 -95
Total Operating Income		 -14 -14 -35 -95 -78
Total Gross Profit		 1.32 1.07 0.99 1.70 3.15
Total Revenue		 1.32 1.07 0.99 1.70 3.15
Operating Revenue		 1.32 1.07 0.99 1.70 3.15
Total Cost of Revenue		 0.00 0.00 0.00 0.00 0.00
Total Operating Expenses		 15 16 36 97 81
Selling, General & Admin Expense		 4.51 5.06 12 21 24
Research & Development Expense		 11 10 24 35 57
Other Operating Expenses / (Income)		 - 0.00 - 41 0.00
Total Other Income / (Expense), net		 -2.97 -5.81 -6.78 -11 -16
Interest Expense		 2.97 5.60 6.97 1.56 0.70
Other Income / (Expense), net		 - -0.21 - -9.63 -16
Income Tax Expense		 0.09 0.03 0.06 0.13 -0.18
Weighted Average Basic Shares Outstanding		 - - 37.14M 40.90M 47.68M
Weighted Average Diluted Shares Outstanding		 - - 37.14M 40.90M 47.68M
Weighted Average Basic & Diluted Shares Outstanding		 - - 37.14M 40.90M 47.68M

Quarterly Income Statements for Oculis

No quarterly income statements for Oculis are available.

Annual Cash Flow Statements for Oculis

This table details how cash moves in and out of Oculis' business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2020 2021 2022 2023 2024
Period end date 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024
Net Change in Cash & Equivalents		 -8.12 45 -29 154 57
Net Cash From Operating Activities		 -14 -15 -27 0.14 -2.59
Net Cash From Continuing Operating Activities		 -14 -16 -32 0.14 -2.59
Net Income / (Loss) Continuing Operations		 -17 -20 -42 0.00 0.00
Depreciation Expense		 0.12 0.10 0.32 0.34 0.45
Non-Cash Adjustments To Reconcile Net Income		 3.29 4.96 7.82 -0.20 -3.04
Net Cash From Investing Activities		 -0.02 -0.03 -3.84 0.00 0.00
Net Cash From Continuing Investing Activities		 -0.02 -0.03 -3.84 0.00 0.00
Net Cash From Financing Activities		 5.49 60 1.85 154 60
Net Cash From Continuing Financing Activities		 5.56 61 2.15 154 60
Cash Interest Received		 - - - 1.47 1.63

Quarterly Cash Flow Statements for Oculis

No quarterly cash flow statements for Oculis are available.

Annual Balance Sheets for Oculis

This table presents Oculis' assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2021 2022 2023 2024
Period end date 12/31/2021 12/31/2022 12/31/2023 12/31/2024
Total Assets		 63 40 136 133
Total Current Assets		 52 26 120 116
Cash & Equivalents		 51 21 46 31
Other Current Assets		 1.03 3.20 63 78
Plant, Property, & Equipment, net		 0.47 0.39 0.34 0.42
Plant, Property & Equipment, gross		 0.47 0.39 0.34 0.42
Total Noncurrent Assets		 11 14 16 17
Intangible Assets		 9.54 13 15 15
Other Noncurrent Operating Assets		 0.93 0.90 1.00 1.96
Total Liabilities & Shareholders' Equity		 63 40 136 133
Total Liabilities		 130 146 25 52
Total Current Liabilities		 4.44 13 23 49
Accounts Payable		 0.90 4.18 9.04 6.47
Accrued Expenses		 3.33 8.67 7.08 20
Other Current Liabilities		 0.21 0.15 0.21 0.35
Total Noncurrent Liabilities		 126 133 1.83 3.02
Capital Lease Obligations		 0.63 0.53 0.51 0.95
Noncurrent Employee Benefit Liabilities		 - - 0.87 2.06
Other Noncurrent Operating Liabilities		 124 - 0.45 0.00
Total Equity & Noncontrolling Interests		 -67 -106 112 81
Total Preferred & Common Equity		 -66 -106 113 83
Preferred Stock		 11 12 343 380
Total Common Equity		 -77 -117 -230 -297
Common Stock		 0.37 0.04 0.44 0.49
Retained Earnings		 -79 -120 -238 -315
Treasury Stock		 -0.11 -0.00 0.00 -0.01
Other Equity Adjustments		 1.82 2.67 7.20 17

Quarterly Balance Sheets for Oculis

No quarterly balance sheets for Oculis are available.

Annual Metrics and Ratios for Oculis

This table displays calculated financial ratios and metrics derived from Oculis' official financial filings.

Metric 2020 2021 2022 2023 2024
Period end date 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024
Growth Metrics		 - - - - -
Revenue Growth		 0.00% -18.53% -7.99% 72.27% 85.12%
EBITDA Growth		 0.00% -6.93% -138.41% -201.54% 10.56%
EBIT Growth		 0.00% -6.71% -139.06% -199.73% 10.43%
NOPAT Growth		 0.00% -5.18% -142.55% -172.24% 17.87%
Net Income Growth		 0.00% -20.78% -106.45% -152.30% 10.47%
EPS Growth		 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Cash Flow Growth		 0.00% -11.29% -79.50% 100.51% -1,978.55%
Free Cash Flow Firm Growth		 0.00% 0.00% -236.95% 15.13% 51.92%
Invested Capital Growth		 0.00% 0.00% 104.03% 1,212.62% 7.56%
Revenue Q/Q Growth		 0.00% 0.00% 0.00% 0.00% 0.00%
EBITDA Q/Q Growth		 0.00% 0.00% 0.00% 0.00% 0.00%
EBIT Q/Q Growth		 0.00% 0.00% 0.00% 0.00% 0.00%
NOPAT Q/Q Growth		 0.00% 0.00% 0.00% 0.00% 0.00%
Net Income Q/Q Growth		 0.00% 0.00% 0.00% 0.00% 0.00%
EPS Q/Q Growth		 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Cash Flow Q/Q Growth		 0.00% 0.00% 0.00% 0.00% 0.00%
Free Cash Flow Firm Q/Q Growth		 0.00% 0.00% 0.00% 0.00% 0.00%
Invested Capital Q/Q Growth		 0.00% 0.00% 0.00% 0.00% 0.00%
Profitability Metrics		 - - - - -
Gross Margin		 100.00% 100.00% 100.00% 100.00% 100.00%
EBITDA Margin		 -1,034.22% -1,357.39% -3,517.22% -6,156.47% -2,974.49%
Operating Margin		 -1,043.14% -1,346.69% -3,550.00% -5,610.08% -2,489.00%
EBIT Margin		 -1,043.14% -1,366.36% -3,550.00% -6,176.56% -2,988.72%
Profit (Net Income) Margin		 -1,275.56% -1,891.13% -4,243.20% -6,214.28% -3,005.50%
Tax Burden Percent		 100.56% 100.15% 100.14% 100.12% 99.81%
Interest Burden Percent		 121.60% 138.20% 119.36% 100.49% 100.75%
Effective Tax Rate		 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Invested Capital (ROIC)		 0.00% 0.00% 0.00% -201.18% -85.67%
ROIC Less NNEP Spread (ROIC-NNEP)		 0.00% 0.00% 0.00% -328.89% 37.75%
Return on Net Nonoperating Assets (RNNOA)		 0.00% 0.00% 0.00% -3,658.18% -12.64%
Return on Equity (ROE)		 0.00% 30.44% 48.50% -3,859.37% -98.31%
Cash Return on Invested Capital (CROIC)		 0.00% 0.00% -3,103.03% -372.87% -92.96%
Operating Return on Assets (OROA)		 0.00% -23.09% -67.66% -119.23% -69.99%
Return on Assets (ROA)		 0.00% -31.96% -80.87% -119.95% -70.39%
Return on Common Equity (ROCE)		 0.00% 35.14% 54.58% 244,900.45% 269.26%
Return on Equity Simple (ROE_SIMPLE)		 0.00% 30.95% 39.60% -93.67% -113.44%
Net Operating Profit after Tax (NOPAT)		 -9.61 -10 -25 -67 -55
NOPAT Margin		 -730.20% -942.68% -2,485.00% -3,927.06% -1,742.30%
Net Nonoperating Expense Percent (NNEP)		 0.00% -40.75% 57.07% 127.71% -123.42%
Return On Investment Capital (ROIC_SIMPLE)		 - - -90.84% -59.60% -66.97%
Cost of Revenue to Revenue		 0.00% 0.00% 0.00% 0.00% 0.00%
SG&A Expenses to Revenue		 342.37% 471.36% 1,213.16% 1,223.72% 764.09%
R&D to Revenue		 800.77% 975.33% 2,436.84% 2,046.68% 1,824.91%
Operating Expenses to Revenue		 1,143.14% 1,446.69% 3,650.00% 5,710.08% 2,589.00%
Earnings before Interest and Taxes (EBIT)		 -14 -15 -35 -105 -94
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 -14 -15 -35 -105 -94
Valuation Ratios		 - - - - -
Price to Book Value (P/BV)		 0.00 0.00 0.00 0.00 0.00
Price to Tangible Book Value (P/TBV)		 0.00 0.00 0.00 0.00 0.00
Price to Revenue (P/Rev)		 0.00 0.00 0.00 108.32 88.58
Price to Earnings (P/E)		 0.00 0.00 0.00 0.00 0.00
Dividend Yield		 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield		 0.00% 0.00% 0.00% 0.00% 0.00%
Enterprise Value to Invested Capital (EV/IC)		 0.00 0.00 0.00 7.81 9.49
Enterprise Value to Revenue (EV/Rev)		 0.00 0.00 0.00 283.45 200.03
Enterprise Value to EBITDA (EV/EBITDA)		 0.00 0.00 0.00 0.00 0.00
Enterprise Value to EBIT (EV/EBIT)		 0.00 0.00 0.00 0.00 0.00
Enterprise Value to NOPAT (EV/NOPAT)		 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Operating Cash Flow (EV/OCF)		 0.00 0.00 0.00 3,491.81 0.00
Enterprise Value to Free Cash Flow (EV/FCFF)		 0.00 0.00 0.00 0.00 0.00
Leverage & Solvency		 - - - - -
Debt to Equity		 0.00 -0.01 -1.25 0.00 0.01
Long-Term Debt to Equity		 0.00 -0.01 -1.25 0.00 0.01
Financial Leverage		 0.00 0.75 -0.35 11.12 -0.33
Leverage Ratio		 0.00 -0.95 -0.60 32.17 1.40
Compound Leverage Factor		 0.00 -1.32 -0.72 32.33 1.41
Debt to Total Capital		 0.00% -0.96% 492.77% 0.46% 1.17%
Short-Term Debt to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00%
Long-Term Debt to Total Capital		 0.00% -0.96% 492.77% 0.46% 1.17%
Preferred Equity to Total Capital		 0.00% -17.28% 43.06% 306.04% 464.59%
Noncontrolling Interests to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital		 0.00% 116.57% -434.76% -205.36% -362.74%
Debt to EBITDA		 0.00 -0.04 -3.83 0.00 -0.01
Net Debt to EBITDA		 0.00 3.44 -3.22 0.43 0.32
Long-Term Debt to EBITDA		 0.00 -0.04 -3.83 0.00 -0.01
Debt to NOPAT		 0.00 -0.06 -5.42 -0.01 -0.02
Net Debt to NOPAT		 0.00 4.95 -4.55 0.68 0.54
Long-Term Debt to NOPAT		 0.00 -0.06 -5.42 -0.01 -0.02
Altman Z-Score		 0.00 0.00 0.00 0.38 -1.80
Noncontrolling Interest Sharing Ratio		 0.00% -15.46% -12.53% 6,445.61% 373.89%
Liquidity Ratios		 - - - - -
Current Ratio		 0.00 11.81 1.97 5.29 2.37
Quick Ratio		 0.00 11.39 1.65 2.01 0.63
Cash Flow Metrics		 - - - - -
Free Cash Flow to Firm (FCFF)		 0.00 106 -146 -124 -60
Operating Cash Flow to CapEx		 -63,309.86% -49,375.77% -706.71% 0.00% 0.00%
Free Cash Flow to Firm to Interest Expense		 0.00 19.02 -20.91 -79.09 -84.44
Operating Cash Flow to Interest Expense		 -4.58 -2.70 -3.89 0.09 -3.68
Operating Cash Flow Less CapEx to Interest Expense		 -4.58 -2.71 -4.44 0.09 -3.68
Efficiency Ratios		 - - - - -
Asset Turnover		 0.00 0.02 0.02 0.02 0.02
Accounts Receivable Turnover		 0.00 0.00 0.00 0.00 0.00
Inventory Turnover		 0.00 0.00 0.00 0.00 0.00
Fixed Asset Turnover		 0.00 2.28 2.28 4.61 8.20
Accounts Payable Turnover		 0.00 0.00 0.00 0.00 0.00
Days Sales Outstanding (DSO)		 0.00 0.00 0.00 0.00 0.00
Days Inventory Outstanding (DIO)		 0.00 0.00 0.00 0.00 0.00
Days Payable Outstanding (DPO)		 0.00 0.00 0.00 0.00 0.00
Cash Conversion Cycle (CCC)		 0.00 0.00 0.00 0.00 0.00
Capital & Investment Metrics		 - - - - -
Invested Capital		 0.00 -117 4.70 62 66
Invested Capital Turnover		 0.00 -0.02 -0.02 0.05 0.05
Increase / (Decrease) in Invested Capital		 0.00 -117 121 57 4.66
Enterprise Value (EV)		 0.00 0.00 0.00 482 630
Market Capitalization		 0.00 0.00 0.00 184 279
Book Value per Share		 $0.00 $0.00 ($3.16) ($6.19) ($7.26)
Tangible Book Value per Share		 $0.00 $0.00 ($3.52) ($6.59) ($7.62)
Total Capital		 0.00 -66 27 112 82
Total Debt		 0.00 0.63 133 0.51 0.95
Total Long-Term Debt		 0.00 0.63 133 0.51 0.95
Net Debt		 0.00 -50 112 -45 -30
Capital Expenditures (CapEx)		 0.02 0.03 3.84 0.00 0.00
Debt-free, Cash-free Net Working Capital (DFCFNWC)		 0.00 -2.58 -8.82 52 36
Debt-free Net Working Capital (DFNWC)		 0.00 48 13 97 67
Net Working Capital (NWC)		 0.00 48 13 97 67
Net Nonoperating Expense (NNE)		 7.18 10 17 39 40
Net Nonoperating Obligations (NNO)		 0.00 -50 111 -50 -15
Total Depreciation and Amortization (D&A)		 0.12 0.10 0.32 0.34 0.45
Debt-free, Cash-free Net Working Capital to Revenue		 0.00% -240.37% -893.53% 3,051.09% 1,154.66%
Debt-free Net Working Capital to Revenue		 0.00% 4,476.96% 1,275.99% 5,733.17% 2,125.51%
Net Working Capital to Revenue		 0.00% 4,476.96% 1,275.99% 5,733.17% 2,125.51%
Earnings Adjustments		 - - - - -
Adjusted Basic Earnings per Share		 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic Shares Outstanding		 0.00 0.00 37.14M 40.90M 47.68M
Adjusted Diluted Earnings per Share		 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Diluted Shares Outstanding		 0.00 0.00 37.14M 40.90M 47.68M
Adjusted Basic & Diluted Earnings per Share		 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 0.00 0.00 37.14M 40.90M 47.68M
Normalized Net Operating Profit after Tax (NOPAT)		 -9.61 -10 -25 -67 -55
Normalized NOPAT Margin		 -730.20% -942.68% -2,485.00% -3,927.06% -1,742.30%
Pre Tax Income Margin		 -1,268.44% -1,888.28% -4,237.17% -6,206.79% -3,011.11%
Debt Service Ratios		 - - - - -
EBIT to Interest Expense		 -4.63 -2.62 -5.03 -67.12 -133.49
NOPAT to Interest Expense		 -3.24 -1.81 -3.52 -42.68 -77.82
EBIT Less CapEx to Interest Expense		 -4.64 -2.62 -5.58 -67.12 -133.49
NOPAT Less CapEx to Interest Expense		 -3.25 -1.81 -4.07 -42.68 -77.82
Payout Ratios		 - - - - -
Dividend Payout Ratio		 0.00% 0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio		 0.00% 0.00% 0.00% 0.00% 0.00%

Quarterly Metrics and Ratios for Oculis

No quarterly metrics and ratios for Oculis are available.

Frequently Asked Questions About Oculis' Financials

When does Oculis's financial year end?

According to the most recent income statement we have on file, Oculis' fiscal year ends in December. Their fiscal year 2024 ended on December 31, 2024.

How has Oculis' net income changed over the last 4 years?

Oculis' net income appears to be on an upward trend, with a most recent value of -$94.59 million in 2024, rising from -$16.79 million in 2020. The previous period was -$105.65 million in 2023. See Oculis' forecast for analyst expectations on what’s next for the company.

What is Oculis's operating income?
Oculis's total operating income in 2024 was -$78.34 million, based on the following breakdown:
  • Total Gross Profit: $3.15 million
  • Total Operating Expenses: $81.48 million
How has Oculis revenue changed over the last 4 years?

Over the last 4 years, Oculis' total revenue changed from $1.32 million in 2020 to $3.15 million in 2024, a change of 139.1%.

How much debt does Oculis have?

Oculis' total liabilities were at $51.80 million at the end of 2024, a 111.1% increase from 2023, and a 60.2% decrease since 2021.

How much cash does Oculis have?

In the past 3 years, Oculis' cash and equivalents has ranged from $21.41 million in 2022 to $50.60 million in 2021, and is currently $30.56 million as of their latest financial filing in 2024.

How has Oculis' book value per share changed over the last 4 years?

Over the last 4 years, Oculis' book value per share changed from 0.00 in 2020 to -7.26 in 2024, a change of -726.1%.


Related Companies

This page (NASDAQ:OCS) was last updated on 5/6/2025 by MarketBeat.com Staff
From Our Partners
Blackrock’s Sending THIS Crypto Higher on Purpose
While everyone's distracted by Bitcoin's moves, a stealth revolution is underway. One altcoin is quietly po...
Crypto 101 Media | Sponsored
3..2..1.. AI 2.0 ignition (don’t sleep on this)
I just put together an urgent new presentation that you need to see right away. In short: I believe we are...
Timothy Sykes | Sponsored
Trump wipes out trillions overnight…
Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...
Porter & Company | Sponsored
Elon just did WHAT!?
As you may recall, Biden and the Fed were working on a central bank digital currency, or CBDC. Had they got...
Brownstone Research | Sponsored
Why Elon put $51 million into this
Why Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT Scientists
True Market Insiders | Sponsored
This Is The Moment You Betray Trump (Or Prove Them Wrong)
They said you wouldn’t last—that Bidenflation, Wall Street selloffs, and DEI funds would break your loyalty to...
Colonial Metals | Sponsored
URGENT: Someone's Moving Gold Out of London...
People who don’t understand the gold market are about to lose a lot of money. Unfortunately, most so-called “g...
Golden Portfolio | Sponsored
Altucher: Turn $900 into $108,000 in just 12 months?
We are entering the final Trump Bump of our lives. But the biggest returns will not be in the stock market.
Paradigm Press | Sponsored